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 Abstract. The effect of acute brief seizures on neocortical c-fos
expression was investigated in rats injected with 5 mg/kg
4-aminopyridine. Electroencephalography in freely moving
animals with implanted neocortical electrodes detected an
average of 2.67 tonic-clonic convulsions within 1 h following
the 4-AP treatment. Tissue samples of the somatosensory
neocortex were collected at 30 min, 1 h, 3 h, 5 h and 8 h
following the treatment for PCR and immunohistochemistry.
The c-fos mRNA displayed the first significant rise at 1 h,
and remained significantly higher through 3 h. The number of
c-fos protein immunoreactive cells was significantly elevated
already at 30 min, peaked at 1 h, and declined by 5 h. We
conclude that in repetitive, brief seizures, the first convulsion
does not increase c-fos RNA transcription, whilst the second
causes a long-lasting gene expression and a large increase
of c-fos protein synthesis. The phenomenon may have
implications in the pathogenesis of human and animal
epilepsies.
Introduction
In human epileptic case histories, the first symptom towards
a long-lasting pathological change is very often an acute,
unprecedented convulsion. Patients experiencing 1-2
unprecedented, idiopathic seizures have an increased risk for
the development of epilepsy (1). Therefore, the detailed
analysis of the molecular events of an acute seizure might
provide useful information concerning the pathogenesis of
epilepsy. The expression of the Fos family member proto-
oncogenes is induced in every animal seizures studied so far,
indicating that the activation of the c-fos promoter may be an
early common pathway in the convulsive state (2-5).
Therefore, combined with the electrophysiological analysis
of the acute seizure on freely moving animals, we applied the
reverse transcription polymerase chain reaction (RT-PCR) to
detect time-related changes of the transcription of the c-fos
gene, and used immunohistochemistry to track the translation
of c-fos protein. We compared the transcription dynamics of
the c-fos gene to the appearance of c-fos immunoreactive
(c-fosIR) cell nuclei, and to the electrophysiological and
behavioural symptoms. In the present experiments, we
utilized 4-aminopyridine (4-AP), a specific K+-channel
blocker, which precipitates well-described acute behavioural
convulsions in experimental animals (5-7).
Materials and methods
Male Wistar rats (200-250 g bwt) bred in the Central Animal
House of Szeged University were used. The animals were
kept in standard conditions with free access to water and
food. The animal experiments were in accordance with the
European Community Council Directive of November 24,
1986 (86/609/EEC) and the Hungarian Animal Act (1998).
Seizures were induced with a single intraperitoneal (i.p.)
injection of 4-AP (Sigma; 5 mg/kg 4-AP, dissolved in
physiological saline, 1.0 mg/ml concentration). Control
animals received the same volume of physiological saline, i.p.
(Table I).
The animals were deeply anesthetised with Nembutal
(50 mg/kg, i.p.) and their heads fixed in a stereotaxic frame.
Stainless steel screw-electrodes were implanted over the
somatosensory cortex (trunk and hindlimb regions) on both
sides according to the stereotaxic coordinates (8). An additional
screw electrode over the cerebellum served as a reference.
Electrode leads were attached to a miniature socket fixed to
the skull with dental acrylic cement. Following a 10 day-
recovery period, the electrodes were connected to the recording
instrument through slip-ring assemblies. The behaviour of
the animals was monitored continuously with video cameras.
Spontaneous EEG signals were recorded before seizure
induction. The EEG activity was recorded continuously for 8 h
following the 4-AP treatment. Signals were amplified 1000-
fold with a commercial multichannel amplifier, filtered
between 0.3-50 Hz, digitised at a sampling rate of 100 Hz
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and stored on computer for off-line analyses. Epileptiform
discharges were analysed with custom written software.
In the RT-PCR experiments, we used 30 rats: three controls
and three 4-AP-treated animals at each sampling time (Table I).
The 4-AP treated rats always displayed behavioural seizures.
The rats were decapitated under diethyl-ether anaesthesia, the
brains were dissected, samples of the somatosensory
neocortex were frozen in liquid nitrogen, homogenized, and
total RNA was extracted by the AGPC method (9). The reverse
transcription (RT) was made from 2 µg RNA (10). The RT
product (1 µl of the 20 µl) was submitted to multiplex
polymerase chain reaction (PCR) in 50 µl volume of Taq
reaction buffer containing 0.05 µM glyceraldehyde-3-
phosphate dehydrogenase (GAPDH) primers, 0.5 µM c-fos
primers, 200 µM dNTP, 1.5 mM MgCl2 and one unit of DNA
polymerase. The sequence of GAPDH primers (10) and the
sequence of c-fos primers (11) have already been described.
Amplification was carried out in 25 cycles after carefully
establishing the linearity for both the GAPDH and c-fos
fragments between 20 and 30 cycles. Identity of the c-fos
PCR fragment (256 bp) and the GAPDH fragment (377 bp)
was confirmed by cloning into and sequencing a pGEM-T
easy vector. The RT-PCR products were separated on 6%
acrylamide gel and stained with ethidium bromide.
Densitometric scanning using ImageQuant (Typhoon 9400
Variable Mode Imager, Molecular Dynamics) was performed
for the quantification of the bands. The Student's t-test and
Newman-Keuls test were used for statistical analysis. The
level of c-fos transcripts in the samples was normalized to the
level of GAPDH mRNA detected from the same amplification.
For immunohistochemistry, brains were fixed by
transcardiac perfusion (4% paraformaldehyde in 0.1 M
phosphate buffer; pH 7.4). Frozen, coronal plane sections
were cut at 20 µm thickness with cryostat. Polyclonal c-fos
antibody (raised in rabbit; Santa Cruz Biotechnology, CA,
USA) and the peroxidase-antiperoxidase (PAP) method was
used for immunohistochemistry. The sections were incubated
in 20% normal pig serum, next in primary c-fos antibody
(1:1000 in 20% normal pig serum), and then in donkey anti-
rabbit IgG (1:40; Jackson Immuno-Research, PA, USA). The
secondary antibody was detected by PAP complex diluted to
1:1000 (Jackson). The peroxidase reaction was localised with
nickel chloride-containing diaminobenzidine tetrahydro-
chloride (Sigma), yielding a black reaction product.
From every animal, five coronal immunohistochemical
sections of identical stereotaxic coordinates were selected.
Within the areas of interest (AOIs), the immunoreactive cell
nuclei were counted using a Nikon Eclipse 600 microscope
equipped with a Spot RT Slider digital camera (1600x1200 dpi
in 8 bits), using the Image Pro Plus 4.5 morphometry
software (Media Cybernetics, Silver Spring, MD, USA). The
counting was performed blinded to the animal treatment. Cell
counts in the S1Tr region of the neocortex (8) were done by
using a 10x objective. The AOI size (0.25 mm2) was the
rectangular image-capturing field of the camera which
included each neocortical layer (I-VI), so that the layers
could be evaluated separately. Frozen sections stained with
cresyl violet were used as reference for the thickness of the
neocortical layers. The data were analysed statistically
comparing sets of findings obtained with the same
magnification. Cell counts were normalised to 1 mm2.
Differences in the number of c-fosIR cells in the control and
convulsing animals were analysed with one-way analysis of
variance (ANOVA), followed by the Bonferroni post hoc
test. A significance criterion of 0.05 was used. The statistical
analysis was performed with SPSS 9.0 software.
MIHÁLY et al:  c-fos mRNA IN NEOCORTICAL SEIZURES4 8 2
Table I. Experimental groups and the number of animals.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Experiments Number of rats Number of rats Recording/sampling times
in the control treated with after 4-AP injection and in
(saline-treated) groups 4-AP controls after saline injection
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Electrophysiology (EEG) (self control) 5 30 min, 1 h, 3 h, 5 h, 8 h
Immunohistochemistry 15 15 30 min, 1 h, 3 h, 5 h, 8 h
Gene expression analysis (RT-PCR) 15 15 30 min, 1 h, 3 h, 5 h, 8 h
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Table II. Features of the EEG seizure activity following 4-AP administration.a
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Duration Duration Duration Duration Duration Duration Frequency Frequency
of first of first of first of second of second of second in tonic in clonic
seizure tonic phase clonic phase seizure tonic phase clonic phase phases phases 
(sec) (sec) (sec) (sec) (sec) (sec) (Hz) (Hz)
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Mean (n=5) 53.53 7.38 46.15 73.44 8.96 64.48 7.77 5.23
SD 4.21 4.10 5.12 13.94 5.26 15.30 1.21 0.98
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
aNo statistical analysis was performed on the EEG data.
–––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––––
Results
The i.p. administration of 4-AP induced generalised tonic-
clonic seizures. During the 8-hour-recording period, two
seizures were detected in each animal except one, in which
three events occurred. The convulsions appeared during the
first hour of the observation. The behavioural sequel of 4-AP
seizures was described in detail previously (7). The first seizure
activity appeared on the EEG with an average latency of
20.70±6.48 min. This event was followed by a second seizure,
and the mean delay between the two seizure events was
16.22±4.86 min. The mean duration of the first discharges
was 53.53±4.21 sec, while the second was significantly
longer, lasting for 73.44±13.94 sec (Table II). Repetitive
spikes characterized each seizure event in the so-called tonic
phase and repetitive spikes at a smaller frequency, as well as
spike-and-wave complexes in the so-called clonic phase
(Fig. 1, Table II). The EEG seizure and the behavioural
symptoms did not last longer than 1 h.
The mRNA of c-fos was detectable in the neocortex of
control and 4-AP treated rats, as was the internal control
GAPDH mRNA (Fig. 2). In control and 4-AP-treated rats,
GAPDH messages were not different. At 30 min following the
treatment, no increase of the intensity of the c-fos mRNA
signal was detected. At 1 h following the 4-AP treatment, the
level of c-fos mRNA increased significantly (P=0.0134). This
increase of c-fos mRNA in 4-AP treated animals was also
maximal and highly significant, compared to levels detected
at other time points (Fig. 3). At 3 h, the increase (compared
to controls) was at the border of significance (P=0.0617).
After that, c-fos mRNA decreased gradually below the
control level by 8 h (Fig. 3).
The c-fosIR cell nuclei were present in every layer of the
neocortex following 4-AP administration (Fig. 4). The increase
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Figure 1. Following 4-AP treatment, neocortical seizure activity appeared in each animal. The representative parts of the records are from control animals,
before the injection of 4-AP (Control), and during the seizure (Initiation, Tonic phase, Clonic phase I, Clonic phase II, Termination). Time and voltage scales
are shown.
Figure 2. Polyacrylamide gel analysis of fragments of multiplex RT-PCR reactions. The upper bands show GAPDH, the lower bands c-fos. The first lane (M)
displays length markers. S, neocortex of 4-AP-treated animals; C, neocortex of rats injected with physiological saline.
of the number of c-fosIR cell nuclei was significant already
at 30 min in layers II, III, IV, V and VI. The highest values
were detected at 1 h in each layer. The increase was still
significant at 3 h following 4-AP injection. Cell counts
decreased to control levels at 5 and 8 h following 4-AP
administration (Fig. 5). The highest elevation in the number
of c-fosIR cells at 30 min was seen in layer IV: other layers
contained less c-fosIR cells. At 1 h, every layer (except layer
I) stained strongly; only layer V stood out with a lower
amount of c-fosIR cells. At 3 h, the number of c-fosIR cells
decreased slightly in layers II, III, IV, V and VI. At 5 h, the
cell numbers decreased to control levels, and remained so at
8 h (Fig. 5). The values in convulsing animals displayed
highly significant differences (P≤0.01) compared to the
controls (Fig. 5). In controls, scattered c-fosIR cells were
seen in layer IV (Fig. 5).
Discussion
Previous studies from our laboratory indicated that the 4-AP
model is reliable for the investigation of seizure genesis, and
that careful counting of c-fosIR cell nuclei serves as an
indicator of seizure spread in forebrain structures, in vivo
(5,12). In the present experiments, the RT-PCR studies
demonstrated the time-related induction, increase and
decrease of the c-fos mRNA in the cerebral cortex following
4-AP injection. This is the first such report in the literature of
4-AP seizures. Another important observation in the present
experiments is that the activation of the c-fos gene lasted
significantly longer than the electrophysiological and
behavioural seizure.
In our experiments, one dose of intraperitoneally applied
4-AP induced at least two seizure events in the animals: this
is what we call brief, repetitive convulsions. In a similar
series of experiments with 5 mg/kg 4-AP, only 70% of the
rats was affected and usually only one tonic-clonic seizure
was detected (6). Compared to our results, the latency of the
seizures was similar, only the duration of the events was
somewhat shorter (6).
Timing of the events was relatively uniform; SD was only
6.48 min in case of the first seizure and 4.86 min for the time
between the seizures. These values are similar to that we
detected with the measuring of the latencies of the symptoms:
in those experiments, the latency of the first tonic-clonic
seizure was 25.8±1.9 min (7). The standard latency of the
first generalised convulsion proves the reliability of the 4-AP
model: indicates that 4-AP penetrates the brain barriers evenly,
and that the elimination of the drug follows a standard kinetics
(13). Our findings concerning the appearance of c-fos in the
convulsing brain are in accordance with previous reports (2,4).
The duration of the second EEG seizure was longer than
that of the first significantly, indicating the sensitization of
large neuronal populations following the first convulsion. In
the neocortex, pyramidal cell interactions are very effective,
probably because of the high cellular density and high degree
of axonal collateralization (14). The pyramidal-to-pyramidal
cell excitatory synapses mainly use NMDA receptors; therefore
they exhibit self-facilitation (14). The result is the reverberant
excitatory activity within a pool of interconnected pyramidal
cells (14). Our recent experiments with in vivo microdialysis
proved that 4-AP convulsions were accompanied by a large
and long-lasting increase of glutamate release (15). Moreover,
seizure events and c-fos expression were dependent on
NMDA-type glutamate receptors (5). Therefore, we think that
the sharp increase of c-fos mRNA in the neocortex reflects
the activation of ionotropic (mainly NMDA-type) glutamate
receptors.
However, the effects of the two repetitive seizure episodes
were different. The first seizure (appearing at 20 min) did not
generate an increase in c-fos mRNA level, as measured at the
30 min RT-PCR sampling time. The second seizure (appearing
30-40 min after the injection) boosted the transcription of c-fos,
causing a highly significant elevation at 1 h, as shown by the
RT-PCR measurements.
On the other hand, the number of c-fosIR cell nuclei was
significantly elevated already at 30 min, indicating that a large
amount of Fos-protein entered the neuronal cell nuclei at the
time when c-fos mRNA levels were not yet elevated. This
discrepancy raises the possibility of the seizure-activated
translocation of the Fos-protein from the cytoplasm to the
nucleus. Literature data indicate that the intranuclear
translocation of the Fos-protein depends on extracellular
signals (16). Our observations support these data and suggest
that neuronal depolarization and the rise of intracellular Ca++
level stimulate the translocation of the c-fos protein (16) from
the cytoplasm to the cell nucleus. The analysis of the different
neocortical layers revealed that lamina IV displayed the most
c-fosIR cells at 30 min, indicating that the activation of the
neocortex probably happened through the thalamocortical
projections (17). This layer retained a relatively high number
of stained cells after 3 h, suggesting that the thalamocortical-
corticothalamic circuits are important in the maintenance of
synchronized neocortical activity (18). Our previous rCBF
measurements proved the large increase of rCBF in the dorsal
diencephalon and the neocortex in 4-AP seizures in mice (19).
Following this line of evidence, we conclude that in acute
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Figure 3. Diagram of c-fos mRNA levels after normalization to the
coamplified GAPDH mRNA. Black columns show the mean values of 4-AP
treated animals, white columns show the mean values of physiological
saline treated rats, vertical bars represent ± SE. The differences compared to
controls are significant at 1 and 3 h (*). The differences between convulsing
animals are very significant at 1 h compared to 0.5, 5 and 8 h (+). Labels:
(+) very significant difference (Newman-Keuls test, P=0.0134); (*)
significant difference (paired t-test, P=0.0617).
neocortical seizure the first cellular event [mediated by the
synchronised activity of thalamocortical afferents (18) during
the first EEG convulsion] is the stimulated translocation of
cytoplasmic c-fos protein to the nucleus, where it binds to the
AP-1 sequence, and can participate in transactivation processes
(3). The second EEG seizure event caused the accumulation
of the molecular activators of the c-fos promoter, and the
large induction of c-fos transcription, as shown by the 1 h peak
of c-fos mRNA. This process could be the result of the
strong activation of Ca++-permeable glutamate receptors in
consequence of seizure-induced intracortical pyramidal-
pyramidal cell interactions (14). At 3 h, both c-fos mRNA and
protein decreased, indicating the decrease of the transcription
and the slow enzymatic breakdown of the synthesized c-fos
protein. Literature data prove that the breakdown occurs via
the ubiquitin/proteasome pathway, indicating that not only
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Figure 4. Immunohistochemistry of c-fos protein in the S1Tr neocortex in 4-AP-injected animals (A, 30 min; B, 1 h; C, 3 h; D, 5 h). Controls are not shown
because they display a staining pattern similar to D. Roman numerals indicate neocortical layers; bar, 500 µm.
Figure 5. Results of the counting of c-fosIR cell nuclei in the neocortex: cell counts in 4-AP seizures at 30 min, 1 h, 3 h, 5 h and 8 h. Solid lines represent cell
counts in 4-AP-treated rats, broken lines represent controls and vertical bars represent ± SE. We noted that the control and 4-AP treated groups differ
significantly in every cases at 1 and 3 h (A-F), and also at 30 min in layers II, III, IV, V, VI (B-F). Asterisks denote significant difference (P<0.01). A, layer I;
B, layer II; C, layer III; D, layer IV; E, layer V; F, layer VI. Slight, non-specific elevation in control animals was due to the handling during the experiment.
the transcription and translation but also the degradation are
strictly controlled processes (20).
Summarizing our results, we conclude that upon the effect
of the first brief convulsion, Fos-proteins move into the cell
nucleus, where they bind to the AP-1. Therefore, the next
convulsion will find functioning c-fos-activated AP-1, and
the effects in terms of transcriptional regulation will be
greater. Based on these results, we think that c-fos (and
probably other IEGs) may act as metaconvulsive agents (21),
facilitating the forthcoming seizure. We propose that
similarly to memory (21), IEGs also act as coincidence
detectors, potentiating the long-time cellular effects of
successive, brief seizures. This process of potentiation and
the coincidence detector effect of the IEGs may have
significance in the pathogenesis of those idiopathic human
epilepsies, which develop due to unprecedented acute
convulsions.
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